✦ LIBER ✦

Effect of fluoxetine on weight reduction in obese patients

✍ Scribed by M Afkhami-Ardekani; H Sedghi

Publisher: Association of Clinical Biochemistry of India
Year: 2005
Tongue: English
Weight: 270 KB
Volume: 20
Category: Article
ISSN: 0970-1915
DOI: 10.1007/bf02893059

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The effects of weight reduction on the r

The effects of weight reduction on the rehabilitation of patients with knee osteoarthritis and obesity

✍ Huang, Mao-Hsiung ;Chen, Chia-Hsin ;Chen, Tien-Wen ;Weng, Ming-Cheng ;Wang, Wen- 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 142 KB 👁 2 views

Influence of weight on aminoglycoside ph

Influence of weight on aminoglycoside pharmacokinetics in normal weight and morbidly obese patients

✍ L. A. Bauer; W. A. Drew Edwards; E. Patchen Dellinger; D. A. Simonowitz 📂 Article 📅 1983 🏛 Springer 🌐 English ⚖ 443 KB

Enoxaparin effect depends on body-weight

Enoxaparin effect depends on body-weight and current doses may be inadequate in obese patients

✍ S. G. Frederiksen; J. L. Hedenbro; L. Norgren 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB 👁 1 views

Effect of dexfenfluramine treatment on b

Effect of dexfenfluramine treatment on body weight, blood pressure and noradrenergic activity in obese hypertensive patients

✍ J. Kolanowski; L. T. Younis; R. Vanbutsele; J. -M. Detry 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 839 KB

The effect of dexfenfluramine (dF) on body weight, blood pressure and noradrenergic activity were studied in 30 obese hypertensive patients randomly divided into two groups and treated for 3 months either with dF (30 mg daily; 16 subjects) or placebo (Pl; 14 subjects). 11 patients from the dF group

No reduction of high density lipoprotein

No reduction of high density lipoprotein2during weight reduction in obese children and adolescents

✍ K. Zwiauer; B. Kerbl; K. Widhalm 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 167 KB

Reduction of food consumption and body w

Reduction of food consumption and body weight of normal and obese mice by chronic treatment with fluoxetine: A serotonin reuptake inhibitor

✍ Terence T. Yen; David T. Wong; Kerry G. Bemis 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 454 KB

Fluoxetine, a serotonin reuptake inhibitor, reduced the food intake and body weight of both normal mice and viable yellow obese mice fed ad libitum. Fluoxetine was given at 10 mg/ kg, i.p., daily for 10 days or fed in the diet at a concentration of 0.04% for 21 days. In both experiments, mice did no